Evolus (EOLS) is a one year old Pharma IPO that recently received an FDA approval (Note the breakout volume). I picked up a chunk of shares at the open at a pull back to $23.57

The Blue arrow shows its recent ICL which may also be an Elliot Wave 2 low. If so, Wave 3 up is just getting started. At the very least I expect a retest of it’s June 2018 high.

https://surfcity.co